Gene · 50652
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNA PCA3 plays a key role in colon cancer occurrence and development. | Arch Med Sci | 2026 | 42540560 | PubTator, text mining | PubMed |
| Morphomechanically-Informed Spatial Curvature Sequencing in Prostate Cancer. | bioRxiv | 2026 | 42539092 | PubTator, text mining | PubMed |
| Innovations in Diagnosis Immunotherapy and Combination Therapy of Prostate Cancer: A Patent-driven Analysis. | Recent Pat Anticancer Drug Discov | 2026 | 42515880 | PubTator, text mining | PubMed |
| Transcriptome-wide profiling of cystic and solid vestibular schwannomas reveals candidate long non-coding RNA signatures. | Mol Biol Rep | 2026 | 42507076 | PubTator, text mining | PubMed |
| Cut-and-Bind Colorimetric Detection of Viral and Non-Coding RNAs Using CRISPR/Cas12a with Zinc Finger-Facilitated Gold Nanoparticle Assembly. | ACS Sens | 2026 | 42485003 | PubTator, text mining | PubMed |
| Sensitive detection of prostate cancer antigen 3 (PCA3) in urine based upon CRISPR/Cas12a and gold nanorods (AuNRs). | Spectrochim Acta A Mol Biomol Spectrosc | 2026 | 42391902 | PubTator, text mining | PubMed |
| Multifactorial diagnostic model combining SAT-PCA3 in prostate cancer. | Discov Oncol | 2026 | 42337216 | PubTator, text mining | PubMed |
| Extracellular vesicles in prostate cancer: current understanding and future perspectives. | J Natl Cancer Cent | 2026 | 42282127 | PubTator, text mining | PubMed |
| Electrochemical biosensor-based strategies for sensitive detection of prostate cancer biomarkers. | Clin Chim Acta | 2026 | 42235733 | PubTator, text mining | PubMed |
| Integrative advances in biomarker-driven prostate cancer management from genomic discovery to precision oncology. | Discov Oncol | 2026 | 42189429 | PubTator, text mining | PubMed |
| Risk Stratification of Suspected Clinically Localized Prostate Cancer Using Multi-Indicator Functional Differentiation: A Predictive Model With fPSA/tPSA, PHI, PCA3, and MRI. | Arch Esp Urol | 2026 | 42104706 | PubTator, text mining | PubMed |
| Study on the detection of prostate cancer using MIRA-CRISPR/Cas12a technology. | Anal Methods | 2026 | 42065511 | PubTator, text mining | PubMed |
| Comparison of prostate cancer diagnostic models based on PCA3 and TMPRSS2:ERG RNA biomarkers from post-DRE and non-DRE urine specimens. | World J Urol | 2026 | 41968196 | PubTator, text mining | PubMed |
| From feasibility to translational pathways: a bibliometric and knowledge-mapping analysis of urine-based liquid biopsy in urologic cancers (2015-2025). | J Transl Med | 2026 | 41882723 | PubTator, text mining | PubMed |
| Enhanced nodal staging by molecular detection of KLK3, FOLH1, and PCA3 in prostate cancer. | Discov Oncol | 2026 | 41843002 | PubTator, text mining | PubMed |
| Editorial Comment on Beyond Total PSA: Clinical Significance of S2,3PSA% in Reducing Unnecessary Prostate Biopsies. | Int J Urol | 2026 | 41837352 | PubTator, text mining | PubMed |
| AMACR and ZFPL1 serum biomarkers enhance precision in predicting postoperative prostate cancer outcomes. | Front Oncol | 2026 | 41783436 | PubTator, text mining | PubMed |
| Real-world monitoring strategies and predictors guiding the transition from active surveillance to treatment in ISUP 1 prostate cancer. | J Cancer Res Clin Oncol | 2026 | 41779210 | PubTator, text mining | PubMed |
| From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. | Transl Oncol | 2026 | 41762538 | PubTator, text mining | PubMed |
| The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. | Front Immunol | 2026 | 41756279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50652/papers